Y
Yoshikazu Inoue
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 273
Citations - 17662
Yoshikazu Inoue is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 48, co-authored 233 publications receiving 12648 citations. Previous affiliations of Yoshikazu Inoue include Niigata University.
Papers
More filters
Journal ArticleDOI
Identification of MICA as a susceptibility gene for pulmonary Mycobacterium avium complex infection.
Junko Shojima,Goh Tanaka,Naoto Keicho,Gen Tamiya,Satoshi Ando,Akira Oka,Yoshikazu Inoue,Katsuhiro Suzuki,Mitsunori Sakatani,Masaji Okada,Nobuyuki Kobayashi,Emiko Toyota,Koichiro Kudo,Akira Kajiki,Hideaki Nagai,Atsuyuki Kurashima,Norihiro Oketani,Hiroshi Hayakawa,Tamiko Takemura,Koh Nakata,Hideyuki Ito,Takatomo Morita,Ikumi Matsushita,Minako Hijikata,Shinsaku Sakurada,Takehiko Sasazuki,Hidetoshi Inoko +26 more
TL;DR: Functional analysis of allelic expression imbalance revealed that A6-derived messenger RNA was more highly expressed than non-A6- derived messenger RNA in human bronchial epithelial cells, suggesting that MICA might be one of the immune molecules affecting the pathogenesis of the disease.
Journal ArticleDOI
Pulmonary Fibrosis on High-Resolution CT of Patients With Pulmonary Alveolar Proteinosis
Masanori Akira,Yoshikazu Inoue,Toru Arai,Chikatoshi Sugimoto,Sayoko Tokura,Koh Nakata,Masanori Kitaichi +6 more
TL;DR: The CT findings of parenchymal fibrosis suggest a poor outcome in patients with autoimmune PAP, and those with fibrosis detected on HRCT during follow-up had a worse prognosis than those without fibrosis detections.
Journal ArticleDOI
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Vincent Cottin,Moisés Selman,Yoshikazu Inoue,Alyson W. Wong,Tamera J. Corte,Kevin R. Flaherty,MeiLan K. Han,Joseph M. Jacob,Kerri A. Johannson,Masanori Kitaichi,Joyce S. Lee,Alvar Agusti,Katerina M. Antoniou,Pauline Bianchi,Fabian Caro,Matias Florenzano,Liam Galvin,Tae Iwasawa,Fernando J. Martinez,Rebecca L. Morgan,Jeffrey L. Myers,Andrew G. Nicholson,Mariaelena Occhipinti,Venerino Poletti,Margaret L. Salisbury,Don D. Sin,Nicola Sverzellati,Thomy Tonia,Claudia Valenzuela,Christopher J. Ryerson,Athol U. Wells +30 more
TL;DR: This statement delineates the syndrome of CPFE and highlights research priorities, and offers a research definition and classification criteria and proposes that studies on CPFE include a comprehensive description of radiologic and, when available, pathological patterns.
Journal ArticleDOI
Long‐term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®‐ON
Jin Woo Song,Takashi Ogura,Yoshikazu Inoue,Zuojun Xu,Manuel Quaresma,Susanne Stowasser,Wibke Stansen,Bruno Crestani +7 more
TL;DR: The efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF) were investigated in the placebo‐controlled INPULSIS® trials.
Journal ArticleDOI
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
Saori Sakaue,Etsuro Yamaguchi,Yoshikazu Inoue,Meiko Takahashi,Jun Hirata,Ken Suzuki,Satoru Ito,Toru Arai,Masaki Hirose,Yoshinori Tanino,Takefumi Nikaido,Toshio Ichiwata,Shinya Ohkouchi,Taizou Hirano,Toshinori Takada,Satoru Miyawaki,Shogo Dofuku,Yuichi Maeda,Takuro Nii,Toshihiro Kishikawa,Kotaro Ogawa,Tatsuo Masuda,Kenichi Yamamoto,Kyuto Sonehara,Ryushi Tazawa,Konosuke Morimoto,Masahiro Takaki,Satoshi Konno,Masaru Suzuki,Keisuke Tomii,Atsushi Nakagawa,Tomohiro Handa,Kiminobu Tanizawa,Haruyuki Ishii,Manabu Ishida,Toshiyuki Kato,Naoya Takeda,Koshi Yokomura,Takashi Matsui,Masaki Watanabe,Hiromasa Inoue,Kazuyoshi Imaizumi,Yasuhiro Goto,Hiroshi Kida,Tomoyuki Fujisawa,Takafumi Suda,Takashi Yamada,Yasuomi Satake,Hidenori Ibata,Nobuyuki Hizawa,Hideki Mochizuki,Atsushi Kumanogoh,Fumihiko Matsuda,Koh Nakata,Tomomitsu Hirota,Mayumi Tamari,Yukinori Okada +56 more
TL;DR: In this paper, the authors conducted a genome-wide association study of aPAP in 198 patients and 395 control participants of Japanese ancestry, finding variants in the major-histocompatibility-complex (MHC) region was significantly associated with disease risk.